Ind-Swift Limited (INDSWFTLTD) - Net Assets

Latest as of March 2025: Rs-4.02 Billion INR ≈ $-43.51 Million USD

Based on the latest financial reports, Ind-Swift Limited (INDSWFTLTD) has net assets worth Rs-4.02 Billion INR (≈ $-43.51 Million USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs7.28 Billion ≈ $78.73 Million USD) and total liabilities (Rs11.30 Billion ≈ $122.24 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check INDSWFTLTD asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets Rs-4.02 Billion
% of Total Assets -55.27%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 50.64

Ind-Swift Limited - Net Assets Trend (2006–2025)

This chart illustrates how Ind-Swift Limited's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Ind-Swift Limited for the complete picture of this company's asset base.

Annual Net Assets for Ind-Swift Limited (2006–2025)

The table below shows the annual net assets of Ind-Swift Limited from 2006 to 2025. For live valuation and market cap data, see market cap of Ind-Swift Limited.

Year Net Assets Change
2025-03-31 Rs-4.02 Billion
≈ $-43.51 Million
+41.76%
2024-03-31 Rs-6.91 Billion
≈ $-74.71 Million
+1.97%
2023-03-31 Rs-7.05 Billion
≈ $-76.21 Million
+2.17%
2022-03-31 Rs-7.20 Billion
≈ $-77.90 Million
-3.62%
2021-03-31 Rs-6.95 Billion
≈ $-75.18 Million
+2.52%
2020-03-31 Rs-7.13 Billion
≈ $-77.12 Million
-5.45%
2019-03-31 Rs-6.76 Billion
≈ $-73.14 Million
-1.98%
2018-03-31 Rs-6.63 Billion
≈ $-71.72 Million
-7.75%
2017-03-31 Rs-6.16 Billion
≈ $-66.56 Million
-150.78%
2016-03-31 Rs-2.45 Billion
≈ $-26.54 Million
-521.36%
2015-03-31 Rs-395.00 Million
≈ $-4.27 Million
-136.44%
2014-03-31 Rs1.08 Billion
≈ $11.72 Million
-50.12%
2013-03-31 Rs2.17 Billion
≈ $23.50 Million
-32.32%
2012-03-31 Rs3.21 Billion
≈ $34.72 Million
-2.65%
2011-03-31 Rs3.30 Billion
≈ $35.67 Million
+17.87%
2010-03-31 Rs2.80 Billion
≈ $30.26 Million
+15.84%
2009-03-31 Rs2.42 Billion
≈ $26.12 Million
+35.54%
2008-03-31 Rs1.78 Billion
≈ $19.27 Million
+19.80%
2007-03-31 Rs1.49 Billion
≈ $16.09 Million
+14.68%
2006-03-31 Rs1.30 Billion
≈ $14.03 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Ind-Swift Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 413160900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Common Stock Rs108.33 Million %
Total Equity Rs-4.02 Billion 100.00%

Ind-Swift Limited Competitors by Market Cap

The table below lists competitors of Ind-Swift Limited ranked by their market capitalization.

Company Market Cap
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
$9.24 Million
Pioneer Lithium Ltd
AU:PLN
$9.24 Million
Thai Coating Industrial Public Company Limited
BK:TCOAT
$9.25 Million
Kwang Jin Ind. Co. Ltd
KQ:026910
$9.25 Million
Bekasi Asri Pemula Tbk
JK:BAPA
$9.23 Million
Pioneer Embroideries Limited
NSE:PIONEEREMB
$9.23 Million
Venzee Technologies Inc
V:VENZ
$9.22 Million
Ta Win Holdings Bhd
KLSE:7097
$9.22 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ind-Swift Limited's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -6,908,252,000 to -4,023,280,000, a change of 2,884,972,000.
  • Net income of 2,834,512,000 contributed positively to equity growth.
  • Other comprehensive income decreased equity by 1,105,020,000.
  • Other factors increased equity by 1,155,480,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Rs2.83 Billion +70.45%
Other Comprehensive Income Rs-1.11 Billion -27.47%
Other Changes Rs1.16 Billion +28.72%
Total Change Rs- %

Book Value vs Market Value Analysis

This analysis compares Ind-Swift Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-03-31 Rs35.02 Rs15.76 x
2007-03-31 Rs40.16 Rs15.76 x
2008-03-31 Rs48.11 Rs15.76 x
2009-03-31 Rs65.21 Rs15.76 x
2010-03-31 Rs75.26 Rs15.76 x
2011-03-31 Rs78.19 Rs15.76 x
2013-03-31 Rs47.06 Rs15.76 x
2014-03-31 Rs22.97 Rs15.76 x
2015-03-31 Rs-7.85 Rs15.76 x
2016-03-31 Rs-48.75 Rs15.76 x
2017-03-31 Rs-113.64 Rs15.76 x
2018-03-31 Rs-122.44 Rs15.76 x
2019-03-31 Rs-124.86 Rs15.76 x
2020-03-31 Rs-131.66 Rs15.76 x
2021-03-31 Rs-128.34 Rs15.76 x
2022-03-31 Rs-132.99 Rs15.76 x
2023-03-31 Rs-130.10 Rs15.76 x
2024-03-31 Rs-127.54 Rs15.76 x
2025-03-31 Rs-74.28 Rs15.76 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ind-Swift Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 55.01%
  • • Asset Turnover: 0.71x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-3.74%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 13.28% 6.32% 0.71x 2.96x Rs42.54 Million
2007 14.02% 5.49% 0.68x 3.75x Rs59.75 Million
2008 17.53% 6.02% 0.72x 4.02x Rs134.24 Million
2009 15.62% 6.36% 0.73x 3.37x Rs135.82 Million
2010 13.12% 5.33% 0.67x 3.67x Rs87.34 Million
2011 13.17% 4.83% 0.73x 3.75x Rs104.71 Million
2013 -51.21% -28.31% 0.28x 6.48x Rs-1.33 Billion
2014 -106.63% -20.28% 0.41x 12.82x Rs-1.26 Billion
2015 0.00% -34.79% 0.34x 0.00x Rs-1.41 Billion
2016 0.00% -70.18% 0.29x 0.00x Rs-1.89 Billion
2017 0.00% -142.71% 0.39x 0.00x Rs-3.11 Billion
2018 0.00% -18.69% 0.44x 0.00x Rs158.88 Million
2019 0.00% 2.86% 0.48x 0.00x Rs758.22 Million
2020 0.00% -5.80% 0.55x 0.00x Rs521.91 Million
2021 0.00% -8.47% 0.52x 0.00x Rs397.00 Million
2022 0.00% -5.12% 0.62x 0.00x Rs520.12 Million
2023 0.00% 6.53% 0.61x 0.00x Rs965.07 Million
2024 0.00% 2.83% 0.77x 0.00x Rs833.14 Million
2025 0.00% 55.01% 0.71x 0.00x Rs3.24 Billion

Industry Comparison

This section compares Ind-Swift Limited's net assets metrics with peer companies in the same industry.

Industry Context

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Ind-Swift Limited (INDSWFTLTD) Rs-4.02 Billion 13.28% N/A $9.23 Million
Allcargo Gati Limited (ACLGATI) $2.90 Billion 3.28% 1.93x $105.06 Million
Dhani Services Limited (DHANI) $3.70 Billion 68.11% 3.17x $342.32 Million
Gujarat Raffia Industries Limited (GUJRAFFIA) $206.35 Million 2.51% 0.26x $4.35K
Inox Wind Energy Limited (IWEL) $21.90 Billion 13.85% 1.35x $1.34 Billion
Mangalore Chemicals & Fertilizers Limited (MANGCHEFER) $-501.25 Million 0.00% 0.00x $395.72 Million
Zodiac Energy Limited (ZODIAC) $360.50 Million 8.85% 1.63x $25.69 Million

About Ind-Swift Limited

NSE:INDSWFTLTD India
Market Cap
$9.23 Million
Rs853.64 Million INR
Market Cap Rank
#27077 Global
#1523 in India
Share Price
Rs15.76
Change (1 day)
+6.13%
52-Week Range
Rs12.47 - Rs18.91
All Time High
Rs33.25
About

Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. The company offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin… Read more